Atlas Trials

HIF-2α Mutated Cancers

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch HIF-2α Mutated Cancers

RecordFirmDate
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015) (NCT04924075)Merck Sharp & Dohme LLC2021-08-12

Track HIF-2α Mutated Cancers automatically

Every clearance here is in the API, with alerts when new ones post.